Ellie Harrison was at a university party when she started chatting to one of her classmates. They were celebrating the start ...

Incomplete immune recovery despite sustained virologic suppression in patients with HIV was associated with increased risk for incident cancer.

Uganda's fight against HIV has shown measurable progress, with more people now accessing testing, treatment, and achieving viral suppression than ever before, according to new 2024 data from the ...

The Australian researchers developed a novel mRNA-based technology capable of reaching the white blood cells where HIV lies ...

From the first reported case of AIDS to the present, what is the history of HIV-AIDS and are there parallels to the COVID-19 pandemic?

Researchers say they've taken a major step toward finding a cure for HIV. As The Guardian reports, scientists at the Peter Doherty Institute for Infection and Immunity in Melbourne found a way to ...

It would be another three years before that virus would get its name HIV, or human immunodeficiency virus, the agency said. In the first 10 years of the HIV/AIDS epidemic, 8-10 million adults were ...

Meeting Coverage > CROI Long-Acting ART Could Prevent More Infant HIV Infections in Zimbabwe — Prioritize access to long-acting antiretrovirals for postpartum women, researcher says by Tara ...

SAN FRANCISCO -- Most patients with HIV who received two broadly neutralizing antibodies (bNAbs) after pausing antiretroviral therapy (ART) avoided rebound for 5 months, a randomized trial showed.

ART has been used to treat HIV for more than 30 years since it was first approved by the FDA in 1987, and highly active ART became available in 1996. 2 The treatment can prolong the life of those ...

The Galway healthcare professional discusses her hopes of opening up wider conversations about the immune condition, and cast aside outdated perceptions ...